Your browser doesn't support javascript.
loading
Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation.
Alkhunaizi, Mansour; Patel, Badar; Bueno, Luis; Bhan, Neel; Ahmed, Tahreem; Arain, Muhammad H; Saliba, Rima; Rondon, Gabriela; Dickey, Burton F; Bashoura, Lara; Ost, David E; Li, Liang; Wang, Shikun; Shpall, Elizabeth; Champlin, Richard E; Mehta, Rohtesh; Popat, Uday R; Hosing, Chitra; Alousi, Amin M; Sheshadri, Ajay.
Afiliação
  • Alkhunaizi M; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Patel B; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Bueno L; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico.
  • Bhan N; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Ahmed T; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Arain MH; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Saliba R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rondon G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dickey BF; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bashoura L; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ost DE; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang S; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mehta R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Popat UR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hosing C; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Alousi AM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sheshadri A; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: asheshadri@mdanderson.org.
Transplant Cell Ther ; 29(3): 204.e1-204.e7, 2023 03.
Article em En | MEDLINE | ID: mdl-36503180
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bronquiolite Obliterante / Transplante de Células-Tronco Hematopoéticas / Doença Pulmonar Obstrutiva Crônica / Síndrome de Bronquiolite Obliterante Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bronquiolite Obliterante / Transplante de Células-Tronco Hematopoéticas / Doença Pulmonar Obstrutiva Crônica / Síndrome de Bronquiolite Obliterante Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article